Freedom of Information Request: 0738 2020/21
University Hospitals Birmingham NHS Foundation Trust (UHB) completed a merger by acquisition of Heart of England NHS Foundation Trust (HEFT) on 1st April 2018. Due to historical differences in data collection/reporting across UHB and the former Heart of England NHS Foundation Trust this response has been provided by hospital site.
Queen Elizabeth Hospital Birmingham:
- In the last 4 months, how many patients with atopic dermatitis have you treated with the following treatments? If you are unable to breakdown or report by condition then please provide numbers of patients treated with the listed drug regardless of indication or condition.
Dupixent (aka Dupilumab) – 1
Rinvoq (aka upadacitinib) – 0
Methotrexate – 1
Ciclosporin – 0
Azathioprine – 0
Mycophenate mefetil – 0
Tacrolimus – 0
Pimecrolimus – 0
Acitretin – 0
Alitretinoin – 0
Ultraviolet light therapy – 0
- How many adult atopic dermatitis patients have been treated in the last four months?
20
- How many paediatric atopic dermatitis patients have been treated in the last four months?
17
Heartlands, Good Hope and Solihull Hospitals:
- In the last 4 months, how many patients with atopic dermatitis have you treated with the following treatments? If you are unable to breakdown or report by condition then please provide numbers of patients treated with the listed drug regardless of indication or condition.Please note we are unable to provide the use of listed drugs by indication or condition – the below figures are number of patients treated for all Dermatology issues
Dupixent (aka Dupilumab) – 55
Rinvoq (aka upadacitinib) – 0
Methotrexate – 117
Ciclosporin – 155
Azathioprine – 24
Mycophenate mefetil – 26
Tacrolimus – 28
Pimecrolimus – 0
Acitretin – 67
Alitretinoin – 4
Ultraviolet light therapy – we do not record this in our pharmacy systems
- How many adult atopic dermatitis patients have been treated in the last four months? Withheld under S12 of the FOI Act, please see below
- How many paediatric atopic dermatitis patients have been treated in the last four months? Withheld under S12 of the FOI Act, please see below
Our pharmacy systems do not record to this detail therefore this data is not held centrally, however this information is likely to be held in patients’ files.
Section 12 of the Freedom of Information (FOI) Act makes provision for public authorities to refuse requests for information where the cost of dealing with them would exceed the appropriate limit, which for local government is set at £450. This represents the estimated cost of one person spending more than 18 hours in determining whether the department holds the information, locating, retrieving and extracting the information.
To collate these figures would require a manual review of records which would take in excess of the 18 hours allowed under the FOI Act, we are therefore exempting this information under Section 12 of the FOI Act.
